Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Asta seeks rights to impotency Rx

Jan. 21, 1997

First market introductions for Bondronat

Jan. 21, 1997

Hoechst launches antidiabetic drug in Germany

Jan. 21, 1997

Human IL-9 reported in patent literature

Jan. 21, 1997

Mochida claims new formulation for ulinastatin

Jan. 20, 1997

Takeda claims new approach to diabetes Rx

Jan. 20, 1997

Troglitazone price-listed in Japan

Jan. 20, 1997

New amylin antagonists from Amylin

Jan. 20, 1997

More antiobesity proteins in the pipeline at Lilly

Jan. 20, 1997

New ACAT inhibitors claimed by DuPont Merck

Jan. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026